| Application no. and date | 17728596.2 (espacenet) (Federated) (European Patent Register), 20170531 | | Patent/reg. no. and date | DK/EP 3464309, 20200610 | | Publication date | 20190410 | | Priority no. and date | GB 201609601, 20160601 | | EP pub. no. and date |
EP 3464309 20190410 | | Effective date | | | Applicant/owner | NuCana plc, 3 Lochside Way
Edinburgh EH12 9DT, GB | | Applicant ref. no. | V2006-033-DK | | Inventor | SERPI, Michaela, c/o School of Pharmacy & Pharmaceutical Sciences
Cardiff University
Redwood Building
King Edward VII Avenue
Cardiff
South Glamorgan CF10 3NB, GB,
GRIFFITH, Hugh, c/o NuCana plc
3Lochside Way
Edinburgh
EH12 9DT, GB,
SLUSARCZYK, Magdalena, c/o School of Pharmacy&Pharmaceutical Sciences
Cardiff University
Redwood Building
King Edward VII Avenue
Cardiff
South Glamorgan CF10 3NB, GB | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/7076 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , C07H 19/173 (2006.01) , C07H 19/207 (2006.01) | | Title | PHOSPHORAMIDATNUKLEOSIDDERIVATER SOM ANTICANCERMIDLER | | Int. application no. | GB2017051549 | | Int. publication no. | WO2017207986 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
